Drug-induced or toxic liver disease with chronic fatty liver disease

Description

This is a chronic drug-induced steatosis characterised by relatively large triglyceride globules, which effectively fill the hepatocyte, displace the nucleus and other intracellular constituents to the periphery. Some patients show steatohepatitis, steatosis with focal necrosis and inflammatory cell infiltrate, leading to the development of cirrhosis.

Index terms

Drug-induced or toxic liver disease with chronic fatty liver disease
Drug-induced or toxic liver disease with chronic fatty liver disease, with cirrhosis
Drug-induced or toxic liver disease with chronic fatty liver disease, with cirrhosis, with complications of cirrhosis

Show allHide

Drug-induced or toxic liver disease with chronic fatty liver disease, with cirrhosis, without complications of cirrhosis
Drug-induced or toxic liver disease with chronic fatty liver disease, without cirrhosis
Drug-induced or toxic liver disease with chronic fatty liver disease, without mention of cirrhosis

Exclusions from above levels

DB94 – Alcoholic liver disease
DB98.5 – Budd-Chiari syndrome
ME10.1 – Unspecified jaundice

Show allHide

01 – Certain infectious or parasitic diseases
02 – Neoplasms
05 – Endocrine, nutritional or metabolic diseases
06 – Mental, behavioural or neurodevelopmental disorders
18 – Complications of pregnancy, childbirth and the puerperium
22 – Injury, poisoning or certain other consequences of external causes

Sibling codes

DB95.3Y – Other specified drug-induced or toxic liver disease with fatty liver
DB95.3Z – Drug-induced or toxic liver disease with fatty liver, unspecified

Foundation entity

Drug-induced or toxic liver disease with chronic fatty liver disease – http://id.who.int/icd/entity/646667356

Allowed postcoordination axes

Part of: DB95.3: Drug-induced or toxic liver disease with fatty liver › DB95: Drug-induced or toxic liver disease › 13: Diseases of the digestive system